South Plains Financial Inc. Acquires New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

South Plains Financial Inc. acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,944 shares of the healthcare conglomerate's stock, valued at approximately $1,489,000. UnitedHealth Group accounts for approximately 1.1% of South Plains Financial Inc.'s holdings, making the stock its 20th largest position.

A number of other institutional investors have also added to or reduced their stakes in the business. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $28,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $30,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.5 %

Shares of UNH stock traded down $1.96 during midday trading on Friday, reaching $398.72. 11,384,114 shares of the stock were exchanged, compared to its average volume of 4,602,582. The firm has a market cap of $362.92 billion, a PE ratio of 25.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company's 50 day moving average is $495.85 and its two-hundred day moving average is $528.74. UnitedHealth Group Incorporated has a 1 year low of $393.11 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the prior year, the business posted $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.11%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

Analysts Set New Price Targets

Several research firms have commented on UNH. Oppenheimer decreased their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a research note on Monday, April 21st. Truist Financial lowered their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research note on Monday, April 21st. Raymond James reiterated a "strong-buy" rating and issued a $540.00 price objective (down previously from $635.00) on shares of UnitedHealth Group in a report on Monday, April 21st. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Robert W. Baird dropped their price objective on UnitedHealth Group from $640.00 to $510.00 and set an "outperform" rating for the company in a research note on Tuesday. Four analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.